Until 2007 Professor Woodman was Professor of Translation Medicine at Cranfield University, prior to becoming chief executive of ICRI Global Research; a privately owned knowledge-based organisation providing support and training in clinical drug development in India, Singapore and the UK. Anthony joined the University of West London in October 2011.
Professor Woodman studied at Sunderland Polytechnic before gaining a master's degree with distinction in experimental pathology / toxicology followed by a doctorate in pathology both from the Royal Postgraduate Medical School, University of London, with postdoctoral experience at Dublin City University and John Radcliffe Hospital, University of Oxford. His research discipline is molecular oncology and specifically the development and implementation of diagnostic and prognostic platforms informing care and management of cancer patients; research that has been undertaken in collaboration with major pharmaceutical companies including Roche (formally Boehringer Mannheim) and GSK. With over 125 full papers and conference proceedings, Professor Woodman's area of translational medicine was rated 4* in the 2008 Research Assessment Exercise.